Direct Medical Expenditure in Different Treatment Models for Patients who have Systemic Lupus Erythematosus with End-Stage Renal Disease

• Main Authors: Chien-Cheng Huang, 黃見成
• Other Authors: Chun-Hung Hsu
• Format: Others
• Language: zh-TW
• Online Access: http://ndltd.ncl.edu.tw/handle/46613935380358636664

碩士 === 元培科技大學 === 健康產業管理研究所 === 101 === Systemic Lupus Erythematosus (SLE), very often occur in women of childbearing age, autoimmune diseases the onset may infringe multiple other organs of the body, severe cases may result in SLE patients faced with End-Stage Renal Disease (ESRD due to lupus nephritis factors) of medical options. Based on the patients with end-stage renal disease (SLE-ESRD) her/his medical options are include Renal transplantation(RT), Hemodialysis(HD) and Peritoneal dialysis(PD). This study, using a retrospective secondary data analysis approach to analyze data from the National Health Insurance Research Database, including Registry for catastrophic illness patients (HV), Details of ambulatory care orders (OO), Ambulatory care expenditures by visits (CD), and Inpatient expenditures by admissions (DD). From 1996-2010, the database was screened in 1998-2009 by the SLE-ESRD patients, discuss its 1998/1/1 onwards until 2009/12/31 to analysis the direct medical expenditure to Renal transplants, Hemodialysis and Peritoneal dialysis. Conclusion: Outpatient visits: HD (33.63 times / year) < RT(36.75 times / year) < PD(37.27 times / year); Outpatient expenses: HD(390,973 points/ year) < RT(407,345 points /year) and PD(414,246 points / year); Hospitalization visits: not significant; Hospitalization expenses: RT(169,677 points / year) < PD (242,838 points / year) < HD(352,635 points / year); Total expenses: RT(487,154 points /year) < HD(541,436 points / year) and PD(568,617 points / year). Based on results of the analysis suggest priorities RT > PD > HD，PD and HD have tradeoff between the loss rate and convenience of life, advise that patients need to discuss with his/her doctor before options.